# K180165: Habib EndoHPB

- Pathway: 510(k) (Traditional)
- Applicant: Emcision, Ltd.
- Decided: Mar 20, 2018 after 57 days
- Product code: KNS (Unit, Electrosurgical, Endoscopic (With Or Without Accessories))
- Device class: 2
- Regulation: 21 CFR 876.4300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K970278 (1997). 3 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K083292: Habib Endohpb, Emcision, Ltd. (2009) Summary page 4.

## Most influential descendants
- K181758: ELRA Electrode (2019), 1 descendant of its own
- K233113: ELRA Electrode (7-2B11S, 7-2B11L, 7-2B22S, 7-2B22L, 7-4B18S, 7-4B18L, 7-4B33S, 7-4B33L) (2023), 0 descendants of its own
- K231533: Habib EndoHPB (2023), 0 descendants of its own

## Indications for use
The Habib EndoHPB is a radiofrequency (RF) catheter which provides bipolar energy to perform partial or complete ablation of tissue in the pancreatic and biliary tracts. The Habib EndoHPB is also intended for use to ablate malignant or benign tissue, notably to perform endoscopic biliary drainage or decompression, prior to stent placement or afterwards, to clear occluded stent.

Source page: https://510kreport.com/device/K180165
Methodology: https://510kreport.com/methodology